Beam Therapeutics vs Maze Therapeutics
BEAM and MAZE side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BEAM and MAZE compare
Beam Therapeutics is the larger company, worth 1.2 times as much as Maze Therapeutics ($2.5B against $2.0B).
Beam Therapeutics scores higher on the StockData Score (7 against 4 for Maze Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BEAM | MAZE |
|---|---|---|
| Size and price | ||
| Market cap | $2.5B | $2.0B |
| Share price | $24.03 | $36.09 |
| Change, 1 year | 6.9% | 11.9% |
| Change, 5 years | −73.2% | – |
| Beta (5Y) | 1.98 | 0.90 |
| Employees | 511 | 141 |
| StockData Score | ||
| Total score | 7 (better) | 4 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 2 (better) | 1 |
| Health score | 2 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 15.9× | – |
| P/B | 2.3× (better) | 4.7× |
| FCF yield | −15.0% | −5.7% (better) |
| Fair value | $24.17 | – |
| Margin of safety | 0.60% | – |
| Growth | ||
| Revenue growth (TTM) | 159% | – |
| Revenue growth, 5Y average | 466% | – |
| Profitability | ||
| Operating margin | −242% | – |
| Net margin | −54.7% | – |
| FCF margin | −239% | – |
| Return on equity | −8.1% (better) | −37.5% |
| Return on invested capital | – | −353% |
| Financial health | ||
| Debt / equity | 0.09 | 0.09 (better) |
| Current ratio | 14.57 (better) | 14.14 |
| Altman Z-score | 2.96 | 12.64 (better) |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 106% | 105% |
| Held by insiders | 3.4% | 16.9% |
| Insider net buying, 12 months | −$19.7M (better) | −$25.0M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 26.1% | 14.5% |
Go deeper
- BEAM stock overview
- BEAM income statement
- BEAM valuation and score
- MAZE stock overview
- MAZE income statement
- MAZE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.